BPC-157: CAS 137525-51-0, formula CHNO, MW 1,419.55 Da
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
This precision medicine model plugs biological holes to reduce risks like cardiovascular disease
External resources for researchers PubChem BPC-157 (CID 9941957) FDA G-SRS BPC-157 (Bepecin) Open-access background: tendon-cell study (preclinical) Related research peptides Disclaimer Used solely for in vitro experiments and cannot be: Used in clinical trials involving humans Administered to humans as part of an experiment or investigation Supplied to another party for human investigational use
One mouse study found no increase in mean lifespan, although maximum-lifespan measurements among the longest-surviving animals changed
UPC 850046282348 Report Incorrect Product Information Incorrect Product Information Thank You